Discounted Cash Flow
Core Laboratories Inc. /De/
—
—
Average annual growth rates
| Metric | 10-Year | 5-Year | 3-Year |
|---|---|---|---|
| Sales | — | — | — |
| Free Cash Flow | — | — | — |
| Average (FCF & NI) | — | — | — |
| Net Income | — | — | — |
Endpoint CAGR (better for long term trend)
| Metric | 10-Year | 5-Year | 3-Year |
|---|---|---|---|
| Sales | — | — | — |
| Free Cash Flow | — | — | — |
| Average (FCF & NI) | — | — | — |
| Net Income | — | — | — |
Projected growth rate
—
—
%
%
Historical inputs (10 fiscal years)
| YEAR | Sales | Net Income | Free Cash Flow | Net Margin | EPS (diluted) |
|---|---|---|---|---|---|
| 2021 | $470.3m | $492.0k | $23.0m | 0.1% | $0.43 |
| 2022 | $489.7m (4.1%) | $205.0k (-58.3%) | $25.0m (8.3%) | 0.0% (-60.0%) | $0.42 (-2.3%) |
| 2023 | $509.8m (4.1%) | $350.0k (70.7%) | $24.8m (-0.7%) | 0.1% (64.0%) | $0.79 (88.1%) |
| 2024 | $523.8m (2.8%) | $753.0k (115.1%) | $52.0m (109.7%) | 0.1% (109.4%) | $0.67 (-15.2%) |
| 2025 | $526.5m (0.5%) | $722.0k (-4.1%) | $30.2m (-41.9%) | 0.1% (-4.6%) | $0.64 (-4.5%) |
Base FCF: — (latest fiscal year)
Discount rate: % —
Terminal growth: —
Projection period: — years
Alt A decline yrs:
Alt B total yrs:
Projected cash flows
| Year | Projected cash flow | Discount Factor | Present Value |
|---|
PV of projected FCF: —
Terminal FCF: —
Terminal value: —
PV of terminal value: —
Enterprise value (DCF): —
Current price: —
—Alternative DCF Models
| Model | Fair Value | Upside | PV(FCFs) | PV(Terminal) | Total Years |
|---|---|---|---|---|---|
| Standard (10yr→TV) | — | — | — | — | 10 + TV |
| Alt A (Gradual Decline) | — | — | — | — | — |
| Alt B (30yr Hard Stop) | — | — | — | N/A | — |
This is a simplified DCF model for illustration. It uses reported free cash flow, a single growth assumption, fixed WACC, and a Gordon Growth terminal value. It is not investment advice.